These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31110901)

  • 1. Procalcitonin: Is This the Promised Biomarker for Critically Ill Patients?
    Fontela PS; Lacroix J
    J Pediatr Intensive Care; 2016 Dec; 5(4):162-171. PubMed ID: 31110901
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
    Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
    J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
    [No Abstract]   [Full Text] [Related]  

  • 3. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature.
    Covington EW; Roberts MZ; Dong J
    Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin-guided antibiotic treatment in critically ill patients.
    Hohn A; Heising B; Schütte JK; Schroeder O; Schröder S
    Langenbecks Arch Surg; 2017 Feb; 402(1):1-13. PubMed ID: 27283067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
    Lee CC; Kwa ALH; Apisarnthanarak A; Feng JY; Gluck EH; Ito A; Karuniawati A; Periyasamy P; Pratumvinit B; Sharma J; Solante R; Swaminathan S; Tyagi N; Vu DM; Zirpe K; Schuetz P
    Clin Chem Lab Med; 2020 Nov; 58(12):1983-1991. PubMed ID: 31926074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-based algorithms to initiate or stop antibiotic therapy in critically ill patients: Is it time to rethink our strategy?
    Lam SW; Bauer SR; Duggal A
    Int J Antimicrob Agents; 2016 Jan; 47(1):20-7. PubMed ID: 26655034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AACC Guidance Document on the Clinical Use of Procalcitonin.
    Chambliss AB; Patel K; Colón-Franco JM; Hayden J; Katz SE; Minejima E; Woodworth A
    J Appl Lab Med; 2023 May; 8(3):598-634. PubMed ID: 37140163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin to guide antibiotic decision making.
    Branche A; Neeser O; Mueller B; Schuetz P
    Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin Levels in Critically Ill Children With Status Asthmaticus.
    Samraj RS; Crotty EJ; Wheeler DS
    Pediatr Emerg Care; 2019 Oct; 35(10):671-674. PubMed ID: 31593980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children.
    Pierce R; Bigham MT; Giuliano JS
    Curr Opin Pediatr; 2014 Jun; 26(3):292-8. PubMed ID: 24739491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients.
    Kopterides P; Tsangaris I
    Minerva Anestesiol; 2012 Jul; 78(7):823-35. PubMed ID: 22561677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.